Author: Healio ophthalmology

Treat-and-extend comparable to monthly injections in AMD

A multicenter 12-month phase 3b study showed that treat-and-extend administration of ranibizumab is “statistically noninferior and clinically comparable” with monthly treatment in patients with neovascular age-related macular degeneration.The TREND study recruited 650 treatment-naïve patients with active choroidal neovascularization secondary to AMD in 90 centers across 18 countries, randomly assigned to treat-and-extend or monthly ranibizumab 0.5 mg.

Gurman says, ‘Our voice is their voice’ in explaining the importance of physician advocacy

At a time when the state of health care is in flux, it is critical that physicians engage in the national debate by telling their stories and those of their patients to help create change, according to Andrew W. Gurman, MD, immediate past president of the AMA.“Our country deserves better, and it is up to us as America’s doctors to keep the health and vitality of our patients, our fellow citizens [and] our friends at the forefront of these discussions,” Gurman said in a presentation at the American Society for (Read more...)

Graham-Cassidy proposal: What you need to know

The latest Republican legislation attempting to “repeal and replace” the Affordable Care Act drafted by Senators Lindsey Graham (R-S.C.) and Bill Cassidy, MD, (R-La.), and thus deemed the Graham-Cassidy proposal, has gained growing disapproval from several health care organizations, including the AMA and the American College of Physicians. Within the past week, the AMA and the American College of Physicians (ACP) sent separate letters to the Senators conveying their strong opposition to the bill, citing as main concerns the loss of health care insurance for millions of Americans and its (Read more...)

FDA finalizes guidelines on interoperable devices

The FDA recently issued final guidelines outlining its nonbinding recommendations for safe and secure interactions among medical devices and other information systems, calling for devices to be designed with interoperability as an objective.The guideline is intended to highlight what medical device manufacturers should consider to provide a “reasonable assurance of safety and effectiveness” for their interoperable medical devices, and provides manufacturers with design considerations and recommendations regarding information to include in premarket submissions and device labeling.

Cambodia, Laos eliminate trachoma

Trachoma, the leading infectious cause of blindness worldwide, has been eliminated as a public health problem in Cambodia and the Lao People’s Democratic Republic, according to a WHO press release.WHO launched the Alliance for the Global Elimination of Trachoma by the year 2020 in 1997, and in 1998 the World Health Assembly passed a resolution targeting trachoma for elimination as a public health problem.

More Democrats than Republicans OK with how media covers science

More Democrats than Republicans think the news media does a good job of covering science, according to the results of a new study.The Pew Research Center polled more than 4,000 U.S. adults and found that although most — 54% — regularly get their science news from general news outlets that cover a range of topics, just 28% believed these sources get the facts right. Specialty sources, including museums, science magazines and documentaries, were trusted more, with around half of respondents saying they are accurate most of the time.

AMA urges Senate to reject Graham-Cassidy proposal

The AMA recently sent a letter to Senate Majority Leader Mitch McConnell and Minority Leader Charles Schumer strongly opposing the Graham-Cassidy legislation, emphasizing that the bill would result in the loss of health insurance coverage for millions of Americans while destabilizing health insurance markets.“Similar to proposals that were considered in the Senate in July, we believe the Graham-Cassidy Amendment would result in millions of Americans losing their health insurance coverage, destabilize health insurance markets, and decrease access to affordable coverage and care,” James L. Madara, MD, CEO and executive vice (Read more...)